ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
35.58
-0.50%
US Tech 100
18,254.40
-0.72%
S&P 500
5,306.04
0.02%
US Dollar vs CAD
1.36579
0.07%
Bitcoin
67,848.39
-0.65%
Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. ARYA Sciences Acquisition Corporation IV (ARYD)

  7. ARYA Sciences Acquisition Corporation IV (ARYD) News

ARYD

ARYA Sciences Acquisitio... (ARYD)

ARYA Sciences Acquisition Corporation IV
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:ARYD
DateTimeSourceHeadlineSymbolCompany
05/20/20248:31PMEdgar (US Regulatory)Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]NASDAQ:ARYDARYA Sciences Acquisition Corporation IV
05/20/20244:25PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ARYDARYA Sciences Acquisition Corporation IV
05/16/20243:41PMEdgar (US Regulatory)Form 425 - Prospectuses and communications, business combinationsNASDAQ:ARYDARYA Sciences Acquisition Corporation IV
05/16/20243:15PMEdgar (US Regulatory)Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSBNASDAQ:ARYDARYA Sciences Acquisition Corporation IV
05/06/20245:25AMGlobeNewswire Inc.Genenta Welcomes New Directors John L. Cantello, Lauren H. Chung, Armon R. Sharei, and Todd WiderNASDAQ:ARYDARYA Sciences Acquisition Corporation IV
02/28/20244:25PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ARYDARYA Sciences Acquisition Corporation IV
02/28/20244:02PMEdgar (US Regulatory)Form 425 - Prospectuses and communications, business combinationsNASDAQ:ARYDARYA Sciences Acquisition Corporation IV
02/26/20243:48PMEdgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:ARYDARYA Sciences Acquisition Corporation IV
02/26/20243:46PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ARYDARYA Sciences Acquisition Corporation IV
02/15/20243:34PMEdgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:ARYDARYA Sciences Acquisition Corporation IV
02/15/20243:33PMEdgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:ARYDARYA Sciences Acquisition Corporation IV
02/14/20243:16PMEdgar (US Regulatory)Form 425 - Prospectuses and communications, business combinationsNASDAQ:ARYDARYA Sciences Acquisition Corporation IV
02/14/20243:15PMEdgar (US Regulatory)Form 8-K/A - Current report: [Amend]NASDAQ:ARYDARYA Sciences Acquisition Corporation IV
02/14/20247:51AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ARYDARYA Sciences Acquisition Corporation IV
02/14/20245:29AMPR Newswire (US)Adagio Medical To List on Nasdaq Through Business Combination with ARYA Sciences Acquisition Corp IV, Enabling Further Commercial and Clinical Development of Innovative Cardiac Ablation TechnologiesNASDAQ:ARYDARYA Sciences Acquisition Corporation IV
02/14/20245:06AMPR Newswire (US)Adagio Medical To List on Nasdaq Through Business Combination with ARYA Sciences Acquisition Corp IV, Enabling Further Commercial and Clinical Development of Innovative Cardiac Ablation TechnologiesNASDAQ:ARYDARYA Sciences Acquisition Corporation IV
02/09/20243:30PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ARYDARYA Sciences Acquisition Corporation IV
02/02/20248:00AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ARYDARYA Sciences Acquisition Corporation IV
02/01/20244:08PMEdgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:ARYDARYA Sciences Acquisition Corporation IV
01/30/20243:30PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ARYDARYA Sciences Acquisition Corporation IV
01/22/20244:20PMEdgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:ARYDARYA Sciences Acquisition Corporation IV
01/02/20246:00AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ARYDARYA Sciences Acquisition Corporation IV
12/04/20236:00AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ARYDARYA Sciences Acquisition Corporation IV
11/09/20233:30PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ARYDARYA Sciences Acquisition Corporation IV
11/02/20233:30PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ARYDARYA Sciences Acquisition Corporation IV
10/02/20234:13PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ARYDARYA Sciences Acquisition Corporation IV
09/27/20233:47PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ARYDARYA Sciences Acquisition Corporation IV
09/05/20235:01AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ARYDARYA Sciences Acquisition Corporation IV
08/11/20233:30PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ARYDARYA Sciences Acquisition Corporation IV
08/02/20233:50PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ARYDARYA Sciences Acquisition Corporation IV
 Showing the most relevant articles for your search:NASDAQ:ARYD

Your Recent History

COIN
DEBTUST
DEBT
UNSW3
DAMETH
Datamine
BIT
F13819
Vontobel Financial Produ...
BIT
P1S9L9
BNP Paribas Issuance
BIT
UV8C34
UniCredit Bank
EU
ALLGO
LARGO
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Canada
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved